What You Should Know:
– Fitbit, the leader in wearable technology, and Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, announced the launch of the Wearables for Metabolic Health (WEAR-ME) pilot study.
– This…
Continue Reading
Behemoth lab test company Quest Diagnostics is partnering with Google’s Fitbit to study how wearable technologies can improve metabolic health. The pilot study, dubbed Wearables for Metabolic Health (WEAR-ME), will combine Fitbit’s behavioral and biometric…
Continue Reading
What You Should Know: Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics, the nation’s leading provider of diagnostic information services, today announced a collaboration involving Ultima’s next generation sequencing…
Continue Reading
The following is a guest article by Jeff Lusby, General Manager, Healthcare IT at Quest Diagnostics
As healthcare organizations come to terms with value-based care, many are hitting the wall of unstructured clinical and administrative…
by Healthcare M&A 06/23/2023 Leave a Comment
What You Should Know:
Quest Diagnostics announced that it has completed its $450M acquisition of Haystack Oncology.Haystack Oncology has developed a highly sensitive minimal-residual disease (MRD) testing technology, based…
Continue Reading
Haystack Oncology was founded to dramatically improve patient outcomes with transformative precision oncology.What You Should Know:Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid…
Continue Reading
